Psychological Adverse Events and Associated Safety Profiles of Doxepin: A Pharmacovigilance Study Using VigiBase
Although no definitive safety signals were detected in our AESI analyses, we identified safety signal for drug abuse. Clinicians should carefully weigh the risks and benefits when prescribing doxepin and emphasize the need for vigilant monitoring of AEs.
Authors
- Mo-Se Lee (ORCID: https://orcid.org/0000-0002-6505-7951)
- Ju‐Young Shin (ORCID: https://orcid.org/0000-0003-1010-7525)
- Dongwon Yoon (ORCID: https://orcid.org/0000-0002-9369-0789)
- Y.J. Kim
- J.S. Lee
- Chae-Young Lee (ORCID: https://orcid.org/0009-0002-4634-8179)
- Minyoung Ha
Institutions
- Samsung (South Korea) (KR)
- Korea Pharma (South Korea) (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Journal of Korean Medical Science
- Published
- 2025-01-01
- DOI
- https://doi.org/10.3346/jkms.2025.40.e260
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Celltrion
- National Research Foundation
- Ministry of Food and Drug Safety
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea